New Zealand markets closed

Microbot Medical Inc. (MBOT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.9401-0.0274 (-2.83%)
At close: 04:00PM EDT
0.9699 +0.03 (+3.17%)
After hours: 05:40PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 13.93M
Enterprise value 7.78M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.10
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.89

Trading information

Stock price history

Beta (5Y monthly) 1.70
52-week change 3-21.14%
S&P500 52-week change 326.36%
52-week high 34.3700
52-week low 30.8600
50-day moving average 31.0600
200-day moving average 31.3867

Share statistics

Avg vol (3-month) 395.21k
Avg vol (10-day) 349.1k
Shares outstanding 514.4M
Implied shares outstanding 614.4M
Float 814.15M
% held by insiders 11.68%
% held by institutions 112.00%
Shares short (30 Apr 2024) 4343.39k
Short ratio (30 Apr 2024) 42.69
Short % of float (30 Apr 2024) 42.70%
Short % of shares outstanding (30 Apr 2024) 42.38%
Shares short (prior month 28 Mar 2024) 4173.28k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 305 Sept 2018
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 305 Sept 2018

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-68.96%
Return on equity (ttm)-182.19%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -9.75M
Net income avi to common (ttm)-10.74M
Diluted EPS (ttm)-1.0500
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.38M
Total cash per share (mrq)0.44
Total debt (mrq)231k
Total debt/equity (mrq)5.13%
Current ratio (mrq)2.09
Book value per share (mrq)0.38

Cash flow statement

Operating cash flow (ttm)-8.53M
Levered free cash flow (ttm)-3.81M